Encontrados 4 documentos, a visualizar página 1 de 1
Acute Macular Neuroretinopathy: An Atypical Hemorrhagic Presentation
Pinto, Christophe; Gouveia, Petra; Mendonça, Luís; Sousa, Keissy; Calvão Santos, Gil; Vaz, FernandoAcute macular neuroretinopathy (AMN) is a rare disease. We report a clinical case of AMN diagnosed in a 46-year-old, Caucasian female with an atypical exuberant hemorrhagic presenta- tion. She referred unilateral paracentral scotomas started 1 day before admission. Fundoscopy revealed several large, dot-and-blot and flame-shaped intraretinal hemorrhages surrounded by reddish-brown, wedge-shaped lesions pointed ...
A Typical Presentation of Purtscher’s Retinopathy
Pinto, Christophe; Gouveia, Petra; Calvão Santos, GilIMAGE DESCRIPTION Purtscher’s retinopathy is a rare, sight-threatening retinal disorder associated with numerous types of trauma. It has been firstly described in 1910 by Otmar Purtscher.1,2 Although the exact pathogenesis remains unclear, all clinical features suggest microembolic occlusion of the retinal precapillary arterioles.3 It frequently leads to sudden but reversible visual loss following the precipita...
Reparação de feridas dos canalículos lacrimais
Dias, Ricardo; Pina, Ana Paula; Gouveia, Petra; Cunha, Ana MariaDescrição de nova técnica para a reparação de feridas dos canalículos lacrimais. A técnica cirúrgica descrita, foi usada em doentes com feridas dos canalículos lacrimais, que recorreram ao serviço de urgência do CHSJ. Pode ser usada em regime de urgência na reparação de feridas dos canalículos, ou em regime de cirurgia programada, na reconstrução de canalículos não reparados, estenosados ou parcialmente obstru...
Safety of dexamethasone intravitreal implant injections for treatment of macula...
Gouveia, PetraPurpose: To assess the safety of the dexamethasone implant in the treatment of macular edema (ME) secondary to retinal vein occlusions. Material and Methods: Retrospective study of patients with ME secondary to central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO) treated with dexamethasone implant (Ozurdex, Allergan Inc, Irvine, CA) from January 2011 through August 2015. Safety assessme...